FOLH1 and metastatic neoplasm: Prostate-specific membrane antigen (PSMA; glutamate carboxypeptidase 2) is a membrane-bound metalloprotease that is highly upregulated in cancerous prostate cells, making it a very attractive target for imaging of primary and metastatic tumors.